A central objective of the CAMI Labex was to ensure that scientific advances in computer-assisted medical interventions could be translated beyond the laboratory and into real clinical and industrial impact. To this end, CAMI actively supported preclinical validation and early clinical transfer of its research outcomes, fostering close interactions between researchers, clinicians, and industrial partners.
These efforts led to the maturation of several approaches toward clinical use, as well as to technology transfer and startup creation, illustrating the Labex’s capacity to bridge fundamental research, clinical needs, and innovation ecosystems. Together, these activities demonstrate CAMI’s role as a catalyst for transforming high-level research into sustainable solutions for healthcare practice.
CLINICAL VALORISATION
9 precinical studies
8 clinical studies
215 animal testing
78 involved surgeons
150 involved patients
INDUSTRIAL VALORISATION
